StockData
Abbott Laboratories logo

Abbott Laboratories

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$110.16+3.96 (+3.73%)

Close on Nov 2, 2026Market cap $190.62BP/E 35.4Yield 2.18%

Abbott Laboratories Neuromodulation Division by Year

Neuromodulation Division (Proclaim XR, Eterna SCS, Liberta RC DBS) — International Revenue ($M) ($M)

QuarterlyAnnual

Abbott Laboratories Neuromodulation Division: $237M in FY2025, up 21.5% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
237
Period ended Dec 31, 2025
Change on a year earlier
+21.5%
195 in FY2024
History
10 years
Since FY2016
Sources
10
Documents cited below

Where the FY2025 figure comes from

“|| Sales 12M25 ($ in millions) | Total | Rhythm Management | Electro- physiology | Heart Failure | Vascular | Structural Heart | Neuro-modulation | Diabetes Care || International | 11,419 | 1,315 | 1,481 | 341 | 1,877 | 1,351 | 237 | 4,817”

Source: SEC Filing (0001628280-26-002982) ↗

Reported in Form 8-K Quarterly Earnings Releases (Item 2.02 Revenue Tables) & Form 10-K/10-Q MD&A.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNeuromodulation Division (Proclaim XR, Eterna SCS, Liberta RC DBS) — International Revenue ($M) ($M)Year on yearSource
FY2025Dec 31, 2025237+21.5%SEC Filing (0001628280-26-002982) ↗
FY2024Dec 31, 2024195+18.2%SEC Filing (0001628280-25-002092) ↗
FY2023Dec 31, 2023165+9.3%SEC Filing (0001628280-24-002009) ↗
FY2022Dec 31, 2022151-8.5%SEC Filing (0001628280-23-001516) ↗
FY2021Dec 31, 2021165+19.6%SEC Filing (0001104659-22-007648) ↗
FY2020Dec 31, 2020138-19.3%SEC Filing (0001104659-21-007942) ↗
FY2019Dec 31, 2019171-1.7%SEC Filing (0001104659-20-005717) ↗
FY2018Dec 31, 2018174+1.2%SEC Filing (0001104659-19-002848) ↗
FY2017Dec 31, 2017172+14.7%SEC Filing (0001104659-18-003691) ↗
FY2016Dec 31, 2016150–SEC Filing (0001104659-17-023826) ↗

Breakdown

What makes up neuromodulation Division

Cite this data

StockData. (2026). Abbott Laboratories Neuromodulation Division ($M), annual FY2016–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/md-nm-rev-intl

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.